Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuto Sumida

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Physical Chemistry Chemical Physics : PCCP|September 29, 2017
A study on an unusual S<sub>N</sub>2 mechanism in the methylation of benzyne through nickel-complexationMakoto Hatakeyama, Yuki Sakamoto, Koji Ogata, et al.
Organic Letters|July 22, 2015
Concise Synthesis of v-CoelenterazinesTakamitsu Hosoya, Rie Iimori, Suguru Yoshida, et al.
Scientific Reports|August 4, 2015
Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZRie Sonamoto, Isao Kii, Yuka Koike, et al.
Plos One|September 21, 2022
Reverse mutants of the catalytic 19 kDa mutant protein (nanoKAZ/nanoLuc) from Oplophorus luciferase with coelenterazine as preferred substrateSatoshi Inouye, Jun-Ichi Sato, Yuiko Sahara-Miura, et al.
Journal of the American Chemical Society|May 17, 2011
Primer preactivation of peptidoglycan polymerasesTsung-Shing Andrew Wang, Tania J Lupoli, Yuto Sumida, et al.
Journal of the American Chemical Society|May 4, 2023
Radical Caging Strategy for Cholinergic OptopharmacologyRikako Nakamura, Takeru Yamazaki, Yui Kondo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome miceAkiko Nakano-Kobayashi, Tomonari Awaya, Isao Kii, et al.
Bioorganic & Medicinal Chemistry|July 7, 2015
Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesisSo Masaki, Isao Kii, Yuto Sumida, et al.
European Journal of Medicinal Chemistry|November 6, 2021
Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1AYuka Miyazaki, Masaki Kikuchi, Koji Umezawa, et al.
Nature Communications|April 23, 2016
Selective inhibition of the kinase DYRK1A by targeting its folding processIsao Kii, Yuto Sumida, Toshiyasu Goto, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Physical Chemistry Chemical Physics : PCCP|September 29, 2017
A study on an unusual S<sub>N</sub>2 mechanism in the methylation of benzyne through nickel-complexationMakoto Hatakeyama, Yuki Sakamoto, Koji Ogata, et al.
Organic Letters|July 22, 2015
Concise Synthesis of v-CoelenterazinesTakamitsu Hosoya, Rie Iimori, Suguru Yoshida, et al.
Scientific Reports|August 4, 2015
Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZRie Sonamoto, Isao Kii, Yuka Koike, et al.
Plos One|September 21, 2022
Reverse mutants of the catalytic 19 kDa mutant protein (nanoKAZ/nanoLuc) from Oplophorus luciferase with coelenterazine as preferred substrateSatoshi Inouye, Jun-Ichi Sato, Yuiko Sahara-Miura, et al.
Journal of the American Chemical Society|May 17, 2011
Primer preactivation of peptidoglycan polymerasesTsung-Shing Andrew Wang, Tania J Lupoli, Yuto Sumida, et al.
Journal of the American Chemical Society|May 4, 2023
Radical Caging Strategy for Cholinergic OptopharmacologyRikako Nakamura, Takeru Yamazaki, Yui Kondo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome miceAkiko Nakano-Kobayashi, Tomonari Awaya, Isao Kii, et al.
Bioorganic & Medicinal Chemistry|July 7, 2015
Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesisSo Masaki, Isao Kii, Yuto Sumida, et al.
European Journal of Medicinal Chemistry|November 6, 2021
Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1AYuka Miyazaki, Masaki Kikuchi, Koji Umezawa, et al.
Nature Communications|April 23, 2016
Selective inhibition of the kinase DYRK1A by targeting its folding processIsao Kii, Yuto Sumida, Toshiyasu Goto, et al.
Pageof 4